Current Assets
Cash & Equivalents
UnitedHealth Group Cash & Equivalents increased by 14.9% to $28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.8%, from $30.72B to $28B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 7.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ4 2012
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase suggests strong liquidity and potential for investment or acquisitions, while a decrease may indicate heavy capital expenditure or cash burn.
Detailed definition
This represents the most liquid assets held by the company, including currency, demand deposits, and short-term investme...
Peer comparison
Standard across all industries; peers typically maintain levels proportional to their operating cash flow requirements.
Metric ID:
cash_and_equivalentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.83B | $21.09B | $21.38B | $25.48B | $24.61B | $38.85B | $23.37B | $41.91B | $41.81B | $38.92B | $25.43B | $28.41B | $26.29B | $32.4B | $25.31B | $30.72B | $28.6B | $27.21B | $24.37B | $28B |
| QoQ Change | — | +6.3% | +1.4% | +19.2% | -3.4% | +57.8% | -39.9% | +79.4% | -0.2% | -6.9% | -34.7% | +11.7% | -7.5% | +23.3% | -21.9% | +21.4% | -6.9% | -4.8% | -10.5% | +14.9% |
| YoY Change | — | — | — | — | +24.1% | +84.2% | +9.3% | +64.5% | +69.9% | +0.2% | +8.8% | -32.2% | -37.1% | -16.7% | -0.5% | +8.1% | +8.8% | -16.0% | -3.7% | -8.8% |
Range$19.83B – $41.91B
CAGR+7.5%
Avg YoY Growth+10.2%
Median YoY Growth+4.1%
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's cash & equivalents?
- UnitedHealth Group (UNH) reported cash & equivalents of $28B in Q1 2026.
- How has UnitedHealth Group's cash & equivalents changed year-over-year?
- UnitedHealth Group's cash & equivalents decreased by 8.8% year-over-year, from $30.72B to $28B.
- What is the long-term trend for UnitedHealth Group's cash & equivalents?
- Over 5 years (2020 to 2025), UnitedHealth Group's cash & equivalents has grown at a 7.6% compound annual growth rate (CAGR), from $16.92B to $24.37B.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid assets that can be accessed immediately.